Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

L. Dai, B.K. Meijers, B. Bammens, H. de Loor, L.J. Schurgers, A.R. Qureshi, P. Stenvinkel, P. Evenepoel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number351
Number of pages11
JournalToxins
Volume12
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • binding
  • calcification
  • coronary
  • deficiency
  • end-stage kidney disease
  • hemodialysis
  • microbial metabolism
  • mortality
  • phosphate binders
  • risk
  • sevelamer
  • uremic toxins
  • vitamin k
  • MORTALITY
  • CORONARY
  • RISK
  • vitamin K
  • DEFICIENCY
  • HEMODIALYSIS
  • CALCIFICATION
  • PHOSPHATE BINDERS
  • BINDING

Cite this